Beraprost Sodium Inhibits P38MAPK Signal Pathway in the Kidney of Type 2 Diabetic Rats
PENG Li,WANG Yang-tian,LI Jie,WANG Jian,FENG Xiao-yun,LIU Zhi-min
DOI: https://doi.org/10.3969/j.issn.1008-8199.2012.05.008
2012-01-01
Abstract:Objective Diabetic nephropathy is one of the most common chronic complications of diabetes mellitus as well as a leading cause of end-stage renal disease.This study was to observe the effect of beraprost sodium(BPS) on the P38 mitogen-activated protein kinase(P38MAPK) signal pathway in the kidney of type 2 diabetic rats.Methods Thirty SD rats were randomly divided into a control,a type 2 diabetes(T2D),and a BPS treatment(BPS).The latter two groups received high-fat diet and low-dose streptozotocin to make T2D models,and then the rats of the BPS group were treated by intragastric administration of BPS at 0.6 mg/kg per day.At last,6 were selected from each group for this study.After 8 weeks of treatment,we examined the body weight(BW),kidney weight(KW),KW/BW ratio,blood glucose(BG),24 h urinary albumin(UAlb/24 h),creatinine(Cr) and blood urea nitrogen(BUN) of all the rats,and detected the expressions of p-P38MAPK,t-P38MAPK,TNF-α,TGF-β1,MMP-9 and COX-2 in the renal cortical tissue by Western blot.Results After 8 weeks of treatment,the T2D group showed significant increases in BG,KW/BW ratio,UAlb/24 h,Cr,BUN and expressions of p-P38 MAPK,TNF-α,MMP-9 and COX-2,but a markedly decreased BW as compared with the control rats(P0.01).In comparison with the T2D rats,the rats in the BPS group exhibited significant decreases in BG,UAlb/24 h and expressions of p-P38 MAPK,TNF-α,MMP-9 and COX-2 than the T2D group(P0.01),as well as in KW/BW ratio,Cr and TGF-β1 expression(P0.05),but a remarkable increase in BW(P0.05).ConclusionBPS can inhibit the P38MAPK signal pathway and the expressions of inflammatory factors,such as TNF-α and COX-2,and plays a protective role in type 2 diabetic rats with nephropathy.